Skip to main content
Equibles
FEED logo

FEED · ENvue Medical, Inc.

Track FEED — free

Use FEED with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about FEED

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.44 +0.06 (+14.70%) At close · Aug 14
Going-concern doubt — flagged May 18, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company’s ability to continue as a going concern for twelve months from the date of issuance of these interim condensed consolidated financial statements.”
View the 10-Q filed May 18, 2026
Market Cap
$2.66M
Shares
6.09M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.44 Open$0.37 Day$0.37–0.48 52W close$0.32–10.70 Avg vol 30d1.3M Short int75K · 1.2% float · 1.0d Short vol34% DataAug 2025–Aug 2026 Filing10-Q · May 18

Raw chart and full-history price indicators begin at the captured split on Aug 12, 2025; bars on opposite sides are not compared.

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed May 18, 2026

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 14.3 · calm Equity put/call 0.52
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −78%
below
Price vs 50-day avg −17%
below
RSI (14) 51
neutral
MACD trend Positive
52-week position 1%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return +5%
trailing
6-month return −83%
trailing
YTD return −81%
this year
Relative strength −96%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +6 funds added
Insider flow Distributing
Net -$144.5K over 90 days · 100% sells
Short interest Falling
1.23% of float · ▼ -53.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
13 holders — near 1-yr high, broad support
Squeeze score 40
low risk · 0–100
Fundamentals
Excellent
Revenue growth +33%
Y/Y
Gross margin 48%
contracting
EPS growth +81%
Y/Y
Free cash flow $-9.4M
Balance sheet $3.1M
net cash
Quant / Vol
risk profile
Very High
Volatility 201%
annualized · 1-yr
Max drawdown −97%
past year
ATR 11.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−78% Bearish
Price vs 50-day avg
−17% Bearish
RSI (14)
51 Neutral
MACD trend
Positive Bullish
52-week position
1% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $1 › 200d $2 — 200d above 50d
Institutional flow Flat
0% holders QoQ · +6 funds added
Insider flow Distributing
Net -$144.5K over 90 days · 100% sells
Short interest Falling
1.23% of float · ▼ -53.6% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
13 holders — near 1-yr high, broad support
Price context
position in its 52-week range
Range low $0 Now $0 · 1% Range high $11
vs 200-day avg -78% vs 50-day avg -17%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
FEED
ENvue Medical, Inc.
this stock
$2.66M -81.1% +33.1% — 1.2%
ABT
Abbott Laboratories
 $194.07B -11.2% +5.7% 31.2 1.3%
SYK
Stryker Corp
 $133.18B -3.5% +11.2% 36.0 2.2%
MDT
Medtronic plc
 $116.83B -5.0% +8.4% 24.5 1.4%
BSX
Boston Scientific Corp
 $75.11B -45.6% +12.5% 21.0 1.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
13
% held
4.8%
Net QoQ
+211.5K sh
Top holder
HRT FINANCIAL LP
Held Float
View
Held by Funds
Fund positions
3
View
Short & Settlement
Short Interest Falling
Shares short
75.0K
Days to cover
1.0d
Change
-86.7K sh
View
Short Volume
Short vol %
34%
As of
Aug 14, 2026
Short Total
View
Fails to Deliver
FTD shares
5.5K
Value
$2.5K
As of
Jul 14, 2026
View
Off-Exchange
Off-exchange %
63.9%
Week of
Jul 6, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$144.5K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$2.6M
Net income (FY)
$-18.2M
EPS diluted
$-26.69
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 14, 2026
This year
9
View
Proposed Sales
Value
$35.1K
Shares
30.0K
Filed
May 13, 2026
View
Exempt Offerings
Offering
$13.5M
Filed
Sep 13, 2023
View

Performance

Raw-price comparisons begin at the captured split on Aug 12, 2025; windows that need an earlier baseline remain unavailable.

5D 20D 120D MTD YTD
FEED +9.3% +5.1% -82.5% +38.3% -81.1%
SPY +0.4% +4.5% +13.8% +3.9% +13.9%
vs SPY +8.9% +0.6% -96.3% +34.4% -94.9%
Key facts CIK 1326706 CUSIP 63008J884 13F (30d) 13 filings 13 filers Visit website

Report a Problem

Category
Description
Email (optional, for follow-up)